BACKGROUND: This study evaluated the feasibility of a technology-enhanced group-based fitness intervention for adolescent and young adult (AYA) survivors of childhood cancer. PROCEDURE: AYA survivors ages 13-25 years were randomized to the intervention (eight in-person group sessions with mobile app and FitBit followed by 4 weeks of app and FitBit only) or waitlist control. Assessments were at 0, 2, 3, 6, and 9 months. Feasibility was evaluated by enrollment, retention, attendance, app engagement, and satisfaction. Secondary outcomes included physical activity, muscular strength/endurance, cardiorespiratory fitness, health-related quality of life, and fatigue. RESULTS:A total of 354 survivors were mailed participation letters; 68 (19%) were screened, of which 56 were eligible and 49 enrolled (88% of those screened eligible, 14% of total potentially eligible). Forty-nine survivors (Mage = 18.5 years, 49% female) completed baseline assessments and were randomized (25 intervention, 24 waitlist). Thirty-seven (76%) completed the postintervention assessment and 32 (65%) completed the final assessment. On average, participants attended 5.7 of eight sessions (range 1-8). Overall intervention satisfaction was high (M = 4.3, SD = 0.58 on 1-5 scale). Satisfaction with the companion app was moderately high (M = 3.4, SD = 0.97). The intervention group demonstrated significantly greater improvement in lower body muscle strength compared to the waitlist postintervention, and small but not statistically significant changes in other secondary measures. CONCLUSIONS: A group-based intervention with a mobile app and fitness tracker was acceptable but has limited reach due to geographical barriers and competing demands experienced by AYA survivors.
RCT Entities:
BACKGROUND: This study evaluated the feasibility of a technology-enhanced group-based fitness intervention for adolescent and young adult (AYA) survivors of childhood cancer. PROCEDURE: AYA survivors ages 13-25 years were randomized to the intervention (eight in-person group sessions with mobile app and FitBit followed by 4 weeks of app and FitBit only) or waitlist control. Assessments were at 0, 2, 3, 6, and 9 months. Feasibility was evaluated by enrollment, retention, attendance, app engagement, and satisfaction. Secondary outcomes included physical activity, muscular strength/endurance, cardiorespiratory fitness, health-related quality of life, and fatigue. RESULTS: A total of 354 survivors were mailed participation letters; 68 (19%) were screened, of which 56 were eligible and 49 enrolled (88% of those screened eligible, 14% of total potentially eligible). Forty-nine survivors (Mage = 18.5 years, 49% female) completed baseline assessments and were randomized (25 intervention, 24 waitlist). Thirty-seven (76%) completed the postintervention assessment and 32 (65%) completed the final assessment. On average, participants attended 5.7 of eight sessions (range 1-8). Overall intervention satisfaction was high (M = 4.3, SD = 0.58 on 1-5 scale). Satisfaction with the companion app was moderately high (M = 3.4, SD = 0.97). The intervention group demonstrated significantly greater improvement in lower body muscle strength compared to the waitlist postintervention, and small but not statistically significant changes in other secondary measures. CONCLUSIONS: A group-based intervention with a mobile app and fitness tracker was acceptable but has limited reach due to geographical barriers and competing demands experienced by AYA survivors.
Authors: Katie A Devine; Ann C Mertens; John A Whitton; Carmen L Wilson; Kirsten K Ness; Jordan Gilleland Marchak; Wendy Leisenring; Kevin C Oeffinger; Leslie L Robison; Gregory T Armstrong; Kevin R Krull Journal: Psychooncology Date: 2017-08-31 Impact factor: 3.894
Authors: David Mizrahi; Claire E Wakefield; Joanna E Fardell; Veronica F Quinn; Qishan Lim; Briana K Clifford; David Simar; Kirsten K Ness; Richard J Cohn Journal: Crit Rev Oncol Hematol Date: 2017-08-26 Impact factor: 6.312
Authors: Jeannie S Huang; Lindsay Dillon; Laura Terrones; Lynn Schubert; William Roberts; Jerry Finklestein; Maria C Swartz; Gregory J Norman; Kevin Patrick Journal: Pediatr Blood Cancer Date: 2014-01-16 Impact factor: 3.167
Authors: Alyssa Le; Hannah-Rose Mitchell; Daniel J Zheng; Jaime Rotatori; John T Fahey; Kirsten K Ness; Nina S Kadan-Lottick Journal: Pediatr Blood Cancer Date: 2016-09-12 Impact factor: 3.167
Authors: Kirsten K Ness; Wendy M Leisenring; Sujuan Huang; Melissa M Hudson; James G Gurney; Kimberly Whelan; Wendy L Hobbie; Gregory T Armstrong; Leslie L Robison; Kevin C Oeffinger Journal: Cancer Date: 2009-05-01 Impact factor: 6.860
Authors: Ronald L Gellish; Brian R Goslin; Ronald E Olson; Audry McDonald; Gary D Russi; Virinder K Moudgil Journal: Med Sci Sports Exerc Date: 2007-05 Impact factor: 5.411
Authors: Lucy Yardley; Bonnie J Spring; Heleen Riper; Leanne G Morrison; David H Crane; Kristina Curtis; Gina C Merchant; Felix Naughton; Ann Blandford Journal: Am J Prev Med Date: 2016-11 Impact factor: 5.043